AIDS News and Research

RSS

First therapeutic vaccine designed from dendritic cells of patient achieves significant response

The therapeutic vaccines are a priority research line of the HIVACAT, the catalan programme for the development of therapeutic vaccines and prevention against the Human Immunodeficiency Virus (HIV). This type of therapeutic vaccine helps the patients who are carriers of the virus, combat infection and control the appearance of AIDS in the same way as with the current antiretroviral treatments.

3 Feb 2011

Politico looks at how proposed budget cuts could affect U.S. foreign aid, including global health funding

Politico examines how Republicans' proposed budget cuts could affect foreign aid funding. The House Republican majority has recommended combining President Barack Obama's "State and foreign aid requests with 'nonsecurity' domestic spending and to cut appropriations to 2008 levels."

3 Feb 2011

Researchers design nanoparticles that make blood clots visible to CT scanner

For almost two decades, cardiologists have searched for ways to see dangerous blood clots before they cause heart attacks. Now, researchers at Washington University School of Medicine in St. Louis report that they have designed nanoparticles that find clots and make them visible to a new kind of X-ray technology.

3 Feb 2011

African first ladies gather to discuss HIV/AIDS

On the sidelines of the African Union Summit in Addis Ababa, Ethiopia, on Monday, the General Assembly of the Organization of African First Ladies Against HIV/AIDS (OAFLA) gathered to discuss the continent's progress against HIV/AIDS, Walta Info reports.

3 Feb 2011

Bill Gates' annual letter calls for focus on eradicating polio, governments to sustain foreign aid

Bill Gates, co-chair of the Bill & Melinda Gates Foundation, "urged developed nations to help him wipe out polio 'once and for all' at an event to release his third annual letter [.pdf] Monday," Agence France-Presse reports.

2 Feb 2011

TEAM TO END AIDS endurance training program launched

AIDS United has officially launched TEAM TO END AIDS, a new endurance training program for all levels of athletes that includes marathon and half marathon coaching. Beginners and experienced athletes can register today at: www.T2EA.com.

2 Feb 2011

Bethany Christian Services creates HIV Adoption Toolkit to educate parents

It is estimated that there are more than one million orphans around the world living with HIV/AIDS. Bethany Christian Services, the nation's largest adoption agency, today announced the creation of the HIV Adoption Toolkit for couples considering adopting children living with HIV/AIDS.

2 Feb 2011

Scientists discover breast cancer cells that dodge immune system, promote tumor growth

Scientists discovered a new way breast cancer cells dodge the immune system and promote tumor growth, providing a fresh treatment target in the fight against the disease. While comparable mechanisms to avoid the immune system have been identified in mice with breast and other cancers, the study tested human breast tumor cells, putting researchers closer to understanding how the disease progresses in real patients.

2 Feb 2011

Intricon introduces new patent-pending APT Open in-the-canal hearing aid

IntriCon Corporation, a designer, developer, manufacturer and distributor of body-worn devices, today announced that it has launched its all-new, patent-pending APT Open in-the-canal hearing aid.

1 Feb 2011

Bill Gates argues the case for polio eradication and expanded childhood immunization

Bill Gates, co-chair of the Bill & Melinda Gates Foundation, argues the case for polio eradication and expanded childhood immunization in his third annual letter released today. The letter, a personal account of his priorities, also calls on governments to invest in foreign aid, even in the face of a tough economic climate.

1 Feb 2011

Johnson & Johnson deal may bring HIV/AIDS drugs to developing countries faster

Johnson & Johnson's Tibotec Pharmaceuticals unit on Thursday announced it had granted multiple licenses to generic drug manufacturers "to provide copies of [the experimental HIV/AIDS drug rilpivirine hydrochloride] TMC278 in sub-Saharan Africa, India and parts of Asia if it's approved by regulators," Bloomberg Businessweek reports.

1 Feb 2011

Viral Genetics enters binding Release and Settlement Agreement with T&T

Viral Genetics, and its President, Haig Keledjian, have entered into a binding Release and Settlement Agreement with Timothy and Thomas LLC and its principals that was approved by the court.

29 Jan 2011

Research sheds light on role of helping in addiction recovery

Participating in community service activities and helping others is not just good for the soul; it has a healing effect that helps alcoholics and other addicts become and stay sober, a researcher from Case Western Reserve University School of Medicine reports.

29 Jan 2011

Exposure to infections in early childhood can protect child from eczema later in life: Study

Exposure to worm infections in the womb may protect a newborn infant from developing eczema, a study funded by the Wellcome Trust suggests. A large trial in Uganda showed that treating a pregnant woman for worm infections increased her child's chances of developing the allergic skin disease.

29 Jan 2011

Recent releases in Global Health

Innovative Health Financing Can Benefit Global Health, Pharma: "The launch of pneumococcal vaccination in Nicaragua under AMC [advance market commitment] has shown that innovative approaches to health financing can benefit both global health and pharmaceutical companies," according to a Lancet Infectious Diseases editorial that describes how the roll-out of GAVI initiative is helping to provide developing countries with low-cost pneumococcal vaccines.

28 Jan 2011

AfrOx and ESMO join to raise international awareness of growing problem of cancer in Africa

To coincide with World Cancer Day 2011, on 4 February, the Africa Oxford Cancer Foundation (AfrOx) and the European Society for Medical Oncology (ESMO) are working together to raise international awareness of the growing problem of cancer in Africa.

28 Jan 2011

Matrix enters licensing agreement with Tibotec for generic Rilpivirine Hydrochloride

Mylan Inc. today announced that its subsidiary Matrix Laboratories Limited has signed an agreement with Tibotec Pharmaceuticals for a non-exclusive license to manufacture, market and distribute a generic version of the non-nucleoside reverse transcriptase inhibitor Rilpivirine Hydrochloride (TMC278), pending its regulatory approval for the treatment of treatment-naive HIV-1-infected adults.

28 Jan 2011

HIV causes specific subset of CD4+ T-cells to age rapidly: Study

In the early years of the AIDS epidemic, being infected with the virus that causes the disease was considered a virtual death sentence. But with the development of antiretroviral therapy, many with HIV are now living much longer. In fact, it is estimated that by 2015, about half of all HIV-positive individuals will be older than 50.

28 Jan 2011

Reuters examines how Russia's 'drug problem' has 'become an AIDS problem'

Reuters, in a piece exploring the issue of heroin use in Russia describes how the country's "drug problem has now become an AIDS problem."

28 Jan 2011

Opinions: Global poverty; Global Fund corruption; Tackling poverty, environmental issues

Ahead of the World Economic Forum in Davos, Switzerland, Laurence Chandy and Geoffrey Gert, both of the Brookings Institution's Global Economy and Development program, reflect on "Poverty's Success Story," a Washington Post opinion piece. They note that the last time the World Bank issued global poverty statistics (the number of people in the world living on less than $1.25 each day) was 2005.

28 Jan 2011

AIDS News and Research

First therapeutic vaccine designed from dendritic cells of patient achieves significant response

Politico looks at how proposed budget cuts could affect U.S. foreign aid, including global health funding

Researchers design nanoparticles that make blood clots visible to CT scanner

African first ladies gather to discuss HIV/AIDS

Bill Gates' annual letter calls for focus on eradicating polio, governments to sustain foreign aid

TEAM TO END AIDS endurance training program launched

Bethany Christian Services creates HIV Adoption Toolkit to educate parents

Scientists discover breast cancer cells that dodge immune system, promote tumor growth

Intricon introduces new patent-pending APT Open in-the-canal hearing aid

Bill Gates argues the case for polio eradication and expanded childhood immunization

Johnson & Johnson deal may bring HIV/AIDS drugs to developing countries faster

Viral Genetics enters binding Release and Settlement Agreement with T&T

Research sheds light on role of helping in addiction recovery

Exposure to infections in early childhood can protect child from eczema later in life: Study

Recent releases in Global Health

AfrOx and ESMO join to raise international awareness of growing problem of cancer in Africa

Matrix enters licensing agreement with Tibotec for generic Rilpivirine Hydrochloride

HIV causes specific subset of CD4+ T-cells to age rapidly: Study

Reuters examines how Russia's 'drug problem' has 'become an AIDS problem'

Opinions: Global poverty; Global Fund corruption; Tackling poverty, environmental issues

Improving healthcare sustainability through carbon data

A New Approach to Preventing Bladder Cancer Recurrence

Bringing real-time analytics to downstream bioprocess monitoring

Latest News